Method validation comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-02. Where a claim depends on a specific study, the study is described rather than over-claimed.
HPLC testing separates dissolved compounds by passing a liquid sample through a column packed with stationary phase. A pump delivers mobile phase at controlled flow, and the sample components interact differently with stationary and mobile phases. Compounds that spend more time in mobile phase elute earlier; those retained by stationary phase elute later. Detectors record elution as peaks, and peak area or height relates to amount. This mechanism underpins quantitative analysis of mixtures.
Most routine HPLC testing uses reversed-phase columns, where the stationary phase is nonpolar and the mobile phase is a polar mixture such as water with an organic solvent. Analytes partition between the two phases according to polarity, size, and charge. Gradients that change solvent composition over time can separate compounds with broad retention ranges. Isocratic conditions keep solvent composition constant and suit simpler mixtures. The choice of column chemistry, pH, and temperature affects selectivity and peak shape.
Method validation demonstrates that an HPLC procedure is suitable for its intended purpose. Common validation parameters include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantification, and robustness. Accuracy reflects agreement with a reference value, while precision describes repeatability under defined conditions. Specificity shows whether the method can measure the analyte in the presence of impurities or matrix components. Validation documents are reviewed before a method is used for routine testing or regulatory submissions.
System suitability testing is performed before and during analytical runs to confirm that the instrument and method are working as expected. Typical checks include retention time, peak area precision, resolution between critical pairs, tailing factor, and theoretical plate count. Acceptance criteria are set in the method or pharmacopeial monograph. If a suitability check fails, the run may be rejected and the instrument or sample preparation may need investigation. This practice helps prevent release of data from a system that has drifted out of control.
| Property | Value | Notes |
|---|---|---|
| Separation mode | Reversed-phase | Nonpolar stationary phase with polar mobile phase |
| Typical column particle size | 3–5 µm | Smaller particles improve resolution but raise pressure |
| Typical flow rate | 0.5–2.0 mL/min | Depends on column dimensions and pressure limits |
| Common detection | UV-Vis absorbance | Requires analytes with chromophores |
| Typical run time | 5–30 min | Varies with method, gradient, and sample complexity |
Quality control laboratories use HPLC to check identity, purity, concentration, and stability of raw materials and finished products. A validated method specifies the column, mobile phase, flow rate, detection wavelength, injection volume, and run time. Samples are prepared and compared against reference standards of known concentration. The resulting chromatogram provides quantitative data, such as assay values and impurity levels. This approach is common in pharmaceutical, food, environmental, and industrial testing where consistent measurements are required.
Method validation demonstrates that an analytical procedure is suitable for its intended purpose. Typical validation characteristics include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantitation, and robustness. Regulatory guidance from bodies such as the International Council for Harmonisation and the United States Pharmacopeia outlines expectations, though specific criteria depend on the product and method. System suitability tests are run before sample analysis to confirm resolution, peak symmetry, column efficiency, and injection repeatability. Failure of these checks can invalidate a batch of measurements.
The latter showed yields for LPC extraction from 1% to 7.5% and toxicity screenings confirm that coniferous trees may contain toxins that can be consumed in small amounts, and additional studies including measuring the quantity of each toxin are needed.
Oxygen-containing compounds – are typically hydrophilic and polar, including materials such as silica gel, limestone (calcium carbonate), and zeolites. Carbon-based compounds – are typically hydrophobic and non-polar, including materials such as activated carbon and graphite. Polymer-based compounds – are polar or non-polar, depending on the functional groups in the polymer matrix.
According to the New York Times, the super PACs criticize politicians who are "insufficiently supportive of the push into artificial intelligence" ahead of the 2026 midterm elections. In February 2026 the nonprofit organization Public First Action, which received a $20 million donation from Anthropic, announced plans to support political candidates that support regulation of AI. In December 2025, Trump signed Executive Order 14365, "Ensuring a National Policy Framework for Artificial Intelligence", which seeks to preempt state regulation. The White House published "A National Legislative Policy Framework for Artificial Intelligence: Legislative Recommendations" in March 2026, a set of recommendations to Congress for federal legislation. The recommendations ask Congress to act in various ways to implement the Trump administration's strategy for artificial intelligence policy. Export controls on AI chips and semiconductors are imposed by the United States, restricting the export of technology and equipment related to artificial intelligence to other countries, primarily targeting China. In January 2026, BIS formalized a flexible license review policy for these transactions. This has happened in the context of a broader trade war. In June 2026, the U.S. Department of Commerce expanded export controls beyond AI hardware by requiring licenses for certain frontier artificial intelligence models from Anthropic, while authorizing release to specified trusted partners.
Sources: en.wikipedia.org
=== June === 21 June – Ahead of the unfolding secret payment scandal, the Director General of RTÉ, Dee Forbes, was suspended from her employment by the RTÉ Board, and later issued a statement defending her record. 22 June The postal service An Post moved from its historic headquarters in the General Post Office building on O'Connell Street in Dublin to new premises at North Wall Quay. RTÉ admitted that it paid its top presenter Ryan Tubridy €345,000 more than publicly declared between 2017 and 2022, in what the chair of its board said was a "serious breach of trust with the public". 24 June – All 30 remaining Argos retail stores in Ireland closed permanently. 25 June – Phase 5a of the BusConnects transport infrastructure programme was launched in Dublin 26 June – Dee Forbes resigned as Director-General of RTÉ with immediate effect, following ongoing controversy over undisclosed payments to broadcaster Ryan Tubridy.
Low density lipoprotein receptor-related protein 1 (LRP1), also known as alpha-2-macroglobulin receptor (A2MR), apolipoprotein E receptor (APOER) or cluster of differentiation 91 (CD91), is a protein forming a receptor found in the plasma membrane of cells involved in receptor-mediated endocytosis. In humans, the LRP1 protein is encoded by the LRP1 gene. LRP1 is also a key signalling protein and, thus, involved in various biological processes, such as lipoprotein metabolism and cell motility, and diseases, such as neurodegenerative diseases, atherosclerosis, and cancer.
==== Venus landings ==== In 1970, the Soviet Union's Venera 7 marked the first time a spacecraft was able to return data after landing on another planet. Venera 7 held a resistant thermometer and an aneroid barometer to measure the temperature and atmospheric pressure on the surface, the transmitted data showed 475 C at the surface, and a pressure of 92 bar. In 1975, Venera 9 established an orbit around Venus and successfully returned the first photography of the surface of Venus. Venera 10 landed on Venus and followed with further photography shortly after. NASA initiated the Pioneer Venus project in 1978, successfully deploying four small probes into the Venusian atmosphere on December 9, 1978. The probes confirmed that Venus has little if any magnetic field, and cameras detected lightning in the atmosphere. The last transmissions were received on October 8, 1992, as its decaying orbit no longer permitted communications. The spacecraft burned up the atmosphere soon after, ending a successful 14-year mission that was planned to last only eight months. In 1981, Venera 13 performed a successful soft-landing on Venus and marked the first probe to drill into the surface of another planet and take a sample. Venera 13 also took an audio sample of the Venusian environment, marking another first. Venera 13 returned the first color images of the surface of Venus, revealing an orange-brown flat bedrock surface covered with loose regolith and small flat thin angular rocks. Venera 14, an identical spacecraft to Venera 13, was launched 5 days apart with a similar mission profile.
Sources: en.wikipedia.org
== Corneal epithelial cells == Corneal epithelial cells present a physical barrier to prevent microbes from reaching the interior of the eye chamber, which is effectively separated from the rest of the body via tight junctions. At the same time, corneal epithelial cells also secrete cytokines to activate microbial defense. One cytokine, interleukin (IL)-1α, is stored in epithelial cells and automatically released when the cell membrane is ruptured by infection or trauma. However, long-term effects of IL-1α can lead to not only enhanced immune infiltration of the cornea, but also neovascularization (formation of new blood vessels), which can lead to a loss of corneal transparency. Therefore, the cornea has also been found to secrete an IL-1α antagonist, IL-1RN, which decreases leucocyte invasion of the cornea and suppresses neovascularization, both of which can help preserve vision.
== Side effects == Oclacitinib lacks the side effects that most JAK inhibitors have in humans; instead, side effects are infrequent, mild, and mostly self-limiting. The most common side effects are gastrointestinal problems (vomiting, diarrhea, and appetite loss) and lethargy. The GI problems can sometimes be alleviated by giving oclacitinib with food. New cutaneous or subcutaneous lumps, such as papillomas, can appear, and dogs face an increased susceptibility to infections such as demodicosis. There is a transient decrease in neutrophils, eosinophils, and monocytes, as well as in serum globulin, while cholesterol and lipase levels increase. The decrease in white blood cells lasts only around 14 days. None of the increases or decreases are clinically significant (i.e. none push their corresponding values out of normal ranges). Less common side effects of oclacitinib include bloody diarrhea; pneumonia; infections of the skin, ear, and/or urinary tract; and histiocytomas (benign tumors). Increases in appetite, aggression, and thirst have also been reported.
== Clinical application == CD38 inhibitors may be used as therapeutics for the treatment of asthma. CD38 has been used as a prognostic marker in leukemia. Daratumumab (Darzalex) which targets CD38 has been used in treating multiple myeloma. The use of Daratumumab can interfere with pre-blood transfusion tests, as CD38 is weakly expressed on the surface of erythrocytes. Thus, a screening assay for irregular antibodies against red blood cell antigens or a direct immunoglobulin test can produce false-positive results. This can be sidelined by either pretreatment of the erythrocytes with dithiothreitol (DTT) or by using an anti-CD38 antibody neutralizing agent, e.g. DaraEx.
== Mechanism == The total protein concentration is readout by an increase in absorbance at 565 nm, which can then be measured using colorimetric techniques, including using microplate readers. Most common reagents, except thiols and SDS, are compatible with the assay. An optimized formulation for the assay to maximize sensitivity in microplate format was described.
Sources: en.wikipedia.org
It separates components in a liquid sample and measures their amounts using a detector. Results can indicate concentration, purity, or identity based on retention time and detector response. The technique works for mixtures that can be dissolved and filtered.
It offers high resolution, reproducibility, and compatibility with many sample types. A single run can separate and quantify multiple analytes. It is common in pharmaceutical, food, environmental, and industrial laboratories.
Samples must be soluble in a suitable mobile phase and free of particles that can block the column. Detector response depends on analyte structure, so some compounds need derivatization or alternative detection. Complex matrices may require extensive sample preparation.
Method validation is the documented process of showing that an HPLC procedure produces reliable results for a defined purpose. It examines parameters such as accuracy, precision, specificity, linearity, and robustness. Regulators and quality systems often require validation before routine use.